Gennova Bio joins CEPI to develop vax against Nipah virus
Gennova Biopharmaceuticals, in partnership with CEPI, will advance the development of a self-amplifying mRNA vaccine against ...
IndiaInfoline3d
Gennova Partners with CEPI to Accelerate Nipah Virus Vaccine Development
Currently there are no authorized vaccines or targeted drugs against Nipah, which kills an estimated 75% of those it infects.
The Financial Express3d
Gennova partners with CEPI to develop saRNA vaccine for Nipah virus
Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...
Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
The Cool Down on MSN3d
Study exposes troubling factor linked to rising pandemic risk: 'Severe consequences'
"Humanity’s broken relationship with nature is driving global changes." Study exposes troubling factor linked to rising ...
Gennova Biopharma partners with CEPI to develop mRNA Nipah vaccine
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
These 24 pathogens could pose greatest threat to public health in UK, check which viruses are included
The 24 pathogen families listed in the reference tool include microorganisms that cause Covid-19 and Nipah virus, among ...